Clinical Trials Sponsored by Mette Zander

Total 32518 results

AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer (IMRT)

Locally Advanced Cervical Cancer | Integrated MRI Based RT as Standard of Care
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma

Sarcoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation

Prostate Cancer | Osteoporosis

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

Healthy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Hypofractionated Radiotherapy for Small Cell Lung Cancer

Small Cell Carcinoma | Lung Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation

Prostatic Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Evaluating Taste and Smell Function and Food and Taste Preferences of Head and Neck Cancer Patients During Radiation Therapy/Chemotherapy

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin

Colorectal Cancer | Metastasis | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Cone Beam CT Scanning in Lung and Bladder Cancer.

Bladder Carcinoma | Small Cell Carcinoma | Lung Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer

Carcinoma, Small Cell

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide

Glioma | Glioblastoma

Canada
British Columbia Cancer Agency
BC Cancer Foundation

Completed

Utilization of Genomic Information to Augment Chemotherapy Decision-making for People With Incurable Malignancies

Advanced Incurable Cancers

Canada
Cancer Research UK

Unknown

Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer

Prostate Cancer

United Kingdom
Barrett Cancer Center

Unknown

Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Cancer Research UK

Unknown

Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom

Ovarian Cancer

United Kingdom
Cancer Research UK

Unknown

Study of Genes and the Environment in Patients With Colorectal Cancer in the East Anglia Region of the United Kingdom

Colorectal Cancer

United Kingdom
Cancer Research UK

Unknown

Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom

Endometrial Cancer

United Kingdom
Cancer Research UK

Unknown

Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma

Lymphoma

United Kingdom
Cancer Research UK

Completed

Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer

Colorectal Cancer

United Kingdom
Cancer Research UK

Unknown

Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer

Gastric Cancer | Esophageal Cancer | Adenocarcinoma of the Gastroesophageal Junction

United Kingdom
Cancer Research UK

Unknown

Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Lymphoma
Cancer Research UK

Completed

Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia

Leukemia

United Kingdom
Cancer Research UK

Unknown

Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma

Lymphoma
Cancer Research UK

Completed

Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer

Head and Neck Cancer

United Kingdom, India
National Cancer Institute (NCI)
Children's Cancer Group

Completed

506U78 in Treating Patients With Refractory Hematologic Cancer

Recurrent Childhood Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Lymphoblastic Lymphoma

United States
Cancer Research UK

Completed

Bryostatin 1 In Treating Patients With Progressive Kidney Cancer

Kidney Cancer

United Kingdom
Cancer Research UK

Completed

Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Pancreatic Cancer

United Kingdom
Duke Cancer Institute
National Cancer Institute (NCI)

Completed

Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer

Colorectal Cancer | Metastatic Cancer

United States
Aichi Cancer Center

Completed

Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx

Head and Neck Cancer

Japan
California Cancer Consortium
National Cancer Institute (NCI)

Completed

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition

United States
National Cancer Institute (NCI)
Children's Cancer Group

Completed

Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor

Sarcoma | Neutropenia

United States, Puerto Rico, Canada, Switzerland, Australia
British Columbia Cancer Agency
BC Cancer Foundation

Unknown

Pilot Study of Partial Breast Irradiation Utilizing Permanent Breast Seed Implant to Treat Breast Cancer

Breast Cancer

Canada
California Cancer Consortium
National Cancer Institute (NCI)

Terminated

Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer

Gastric Cancer

United States
California Cancer Consortium
National Cancer Institute (NCI)

Completed

Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Lung Cancer

United States
Dana-Farber Cancer Institute
Prostate Cancer Foundation

Recruiting

Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial

PROSTATE CANCER | Metastatic Prostate Cancer | Metastatic Prostate Carcinoma

United States
Dana-Farber Cancer Institute
Prostate Cancer Foundation

Recruiting

Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial

Prostatic Neoplasms | Prostate Cancer

United States
Dana-Farber Cancer Institute
Conquer Cancer Foundation

Recruiting

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Inflammatory Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast

United States
British Columbia Cancer Agency
BC Cancer Foundation

Recruiting

Personalized Oncogenomics (POG) Program of British Columbia

Advanced Cancers | Metastatic Cancers | Cancers That Cannot be Treated With Curative Intent

Canada
Dana-Farber Cancer Institute
Prostate Cancer Foundation

Completed

Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy

Prostate Cancer

United States
The Netherlands Cancer Institute
Dutch Cancer Society

Completed

Hippocampus Avoidance PCI vs PCI (HA-PCI)

Small Cell Lung Cancer | Lung Cancer

Netherlands, Belgium
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients

Metastatic Solid Malignancies | Locally Advanced Solid Malignancies

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Studying if Adding Night Compression to Standard Care Will Have Improved Control of Lymphedema in Breast Cancer Subjects (LYNC)

Breast Cancer | Lymphedema

Canada
The Netherlands Cancer Institute
Dutch Cancer Society

Completed

To Decrease Fatigue With Light Therapy (SPARKLE)

Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma

Netherlands
AHS Cancer Control Alberta
Alberta Cancer Foundation

Unknown

Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma (NivoPlus)

SCCHN

Canada
British Columbia Cancer Agency
BC Cancer Foundation

Completed

The Oncopanel Pilot (TOP) Study

Gastrointestinal Stromal Tumors | Colorectal Cancer Metastatic | Advanced Melanoma | Advanced Non-Small Cell Lung Carcinoma | Patients With Diagnosed Malignancies Being Considered for Clinical Trials

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy

Prostate Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

Metabolism of Lipids in Advanced Cancer

Lung Neoplasms | Cachexia

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

The Feasibility of Physical Activity in Advanced Cancer Patients

Advanced Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer

Lung Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

Lymphoma | Lung Neoplasms | Colorectal Neoplasms | Brain Neoplasms | Thyroid Neoplasms

Canada

Clinical Trials Sponsored by Mette Zander

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations